Fig. 4: A comparison of 30-day events among patients living with and without obesity in each database, by COVID-19 cohort type (diagnosed and hospitalized). | International Journal of Obesity

Fig. 4: A comparison of 30-day events among patients living with and without obesity in each database, by COVID-19 cohort type (diagnosed and hospitalized).

From: Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom

Fig. 4

Proportion of outcomes for COVID-19 patients living with obesity (red) and without obesity (blue) are depicted in overlapped horizontal bars. The gray color is the overlap between groups. E.g., in the diagnosed cohort, 20 and 10% of patients living with and without obesity in SIDIAP, respectively, were hospitalized. Outcomes with a meaningful difference (|SMD| > 0.1) between patients living with obesity and patients without obesity are marked with an asterisk (*). ARDS acute respiratory distress syndrome, COVID-19 coronavirus disease 2019, CPRD Clinical Practice Research Datalink, CUIMC Columbia University Irving Medical Center, SIDIAP Information System for Research in Primary Care, SMD standardized mean difference, STARR-OMOP Stanford Medicine Research Data Repository, VA-OMOP United States Department of Veterans Affairs.

Back to article page